Jupiter Life Line Hospitals Shows Strong Financial Growth and Operational Efficiency
Jupiter Life Line Hospitals has recently adjusted its evaluation, highlighting changes in performance indicators. The company reported Q3 FY24-25 net sales of Rs 643.22 crore, a 20.05% increase, and achieved a high operating profit margin of 23.39%. Strong institutional holdings reflect confidence in its fundamentals.
Jupiter Life Line Hospitals has recently undergone an evaluation adjustment, reflecting a shift in its underlying trends and performance indicators. The company, operating within the Hospital & Healthcare Services sector, has demonstrated notable financial metrics, including a high return on capital employed (ROCE) of 23.30% and a low debt-to-equity ratio, which stands at an average of 0 times. In the latest quarter, Q3 FY24-25, Jupiter Life Line Hospitals reported net sales of Rs 643.22 crore, marking a growth of 20.05%. The operating profit to net sales ratio reached its highest at 23.39%, showcasing the company's operational efficiency. Additionally, the stock has shown a strong market performance, generating a return of 44.94% over the past year, significantly outpacing the broader market's performance.
The technical indicators for the stock have also shifted positively, with several metrics reflecting a bullish trend. High institutional holdings at 25.79% further indicate confidence in the company's fundamentals.
For more insights on Jupiter Life Line Hospitals and its financial trend performance, you can Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
